These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12491944)

  • 21. Neurofibromatosis type 1 (NF1): the search for mutations by PCR-heteroduplex analysis on Hydrolink gels.
    Shen MH; Harper PS; Upadhyaya M
    Hum Mol Genet; 1993 Nov; 2(11):1861-4. PubMed ID: 7904209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of the R1748X mutation in the NF1 gene in a Brazilian patient with ectropion uveae.
    Trovó-Marqui AB; Goloni-Bertollo EM; Teixeira MF; Tajara EH
    Ophthalmic Res; 2004; 36(6):349-52. PubMed ID: 15627836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protein truncation test.
    Hardy CA
    Methods Mol Biol; 2002; 187():87-108. PubMed ID: 12013755
    [No Abstract]   [Full Text] [Related]  

  • 24. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
    Stockley TL; Ray PN
    Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
    [No Abstract]   [Full Text] [Related]  

  • 27. Independent NF1 mutations in two large families with spinal neurofibromatosis.
    Messiaen L; Riccardi V; Peltonen J; Maertens O; Callens T; Karvonen SL; Leisti EL; Koivunen J; Vandenbroucke I; Stephens K; Pöyhönen M
    J Med Genet; 2003 Feb; 40(2):122-6. PubMed ID: 12566521
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.
    Fu Y; Zhang JQ; Jiang CL; Wang HY
    J Dermatol; 2018 Aug; 45(8):986-988. PubMed ID: 29952103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.
    Wallis D; Li K; Lui H; Hu K; Chen MJ; Li J; Kang J; Das S; Korf BR; Kesterson RA
    Hum Mutat; 2018 Jun; 39(6):816-821. PubMed ID: 29522274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
    Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
    Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of the neurofibromatosis type 1 protein product.
    DeClue JE; Cohen BD; Lowy DR
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinatorial sequencing-by-hybridization: analysis of the NF1 gene.
    Schirinzi A; Drmanac S; Dallapiccola B; Huang S; Scott K; De Luca A; Swanson D; Drmanac R; Surrey S; Fortina P
    Genet Test; 2006; 10(1):8-17. PubMed ID: 16544997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for truncated NF1 proteins.
    Heim RA; Silverman LM; Farber RA; Kam-Morgan LN; Luce MC
    Nat Genet; 1994 Nov; 8(3):218-9. PubMed ID: 7874161
    [No Abstract]   [Full Text] [Related]  

  • 36. Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.
    Faden DL; Asthana S; Tihan T; DeRisi J; Kliot M
    PLoS One; 2017; 12(1):e0170348. PubMed ID: 28099461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient.
    Colapietro P; Gervasini C; Natacci F; Rossi L; Riva P; Larizza L
    Hum Genet; 2003 Nov; 113(6):551-4. PubMed ID: 13680360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New evidence for a mutation hotspot in exon 37 of the NF1 gene.
    Böddrich A; Robinson PN; Schülke M; Buske A; Tinschert S; Nürnberg P
    Hum Mutat; 1997; 9(4):374-7. PubMed ID: 9101303
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations.
    Fernandez E; Bienvenu T; Desclaux Arramond F; Beldjord K; Kaplan JC; Beldjord C
    PCR Methods Appl; 1993 Oct; 3(2):122-4. PubMed ID: 8268787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.